Blood disorder drugs
Companies that make drugs and gene therapies for blood diseases that aren't cancer, like sickle cell disease.
+2.3%
over 3 months · S&P 500 −2.1%
Key indicators
Health
54 / 100
Fragile
Solid
Price
P/E 25
Cheap
Expensive
Up over 1 year
5 of 8
Wallets over 90 days
1 / 2 buys / sells
Buys
Sells
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 9 companies
VRTX
+4.5%
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
V
Vertex Pharmaceuticals
VRTX
87.6%
+4.5%
P
Protagonist Therapeutics
PTGX
5.5%
−17.4%
I
Disc Medicine
IRON
2.5%
−0.1%
B
Beam Therapeutics
BEAM
1.5%
−15.8%
A
Agios Pharmaceuticals
AGIO
1.2%
−6.1%
C
Hemab Therapeutics
COAG
1.2%
−23.8%
R
Rigel Pharmaceuticals
RIGL
0.5%
+4.7%
C
CRISPR Therapeutics
CRSP
−22.2%
S
Silence Therapeutics
SLN
+38.2%